Acorda Therapeutics, Inc. (ACOR) earnings
Quarterly and annual ACOR reports and results, each read against the price at its own news timestamp. Back to the ACOR overview →
7 measured ACOR earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Acorda Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K/A Acorda Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024 | Press release | -6.66% | +13.12% | |
| Form 10-K Acorda Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -6.66% | +13.12% | |
| Form 10-Q Acorda Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | +2.69% | |
| Acorda Therapeutics Reports Third Quarter 2023 Financial Results | Press release | — | +2.69% | |
| Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023 | Press release | — | +2.04% |
Keep exploring
More ACOR: analyst actions → · SEC filings → · ACOR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| QRONS INC (QRON) | 24 | -3.23% | 0% |
| REFLECT SCIENTIFIC INC (RSCF) | 24 | 0.00% | 45% |
| NUTRA PHARMA CORP (NPHC) | 23 | 0.00% | 0% |
| NEUTRA CORPORATION (NTRR) | 23 | 0.00% | 21% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.